Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2012
11/29/2012WO2012162108A2 Boron-containing compositions and methods therefor
11/29/2012WO2012161677A1 TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
11/29/2012WO2012161562A1 A process for producing nano-capsules and nano-beadlets containing phytonutrients derived from palm oil
11/29/2012WO2012161520A2 Injectable liquid composition containing docetaxel
11/29/2012WO2012161492A1 Method for preparing microparticles with reduced initial burst and microparticles prepared thereby
11/29/2012WO2012161448A1 Pharmaceutical composition for oral administration in form of suspension comprising revaprazan or its salt
11/29/2012WO2012161240A1 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
11/29/2012WO2012161196A1 LIPOSOME CONTAINING shRNA MOLECULE FOR THYMIDYLATE SYNTHASE, AND USE FOR SAME
11/29/2012WO2012160485A1 Composition comprising interferon alpha
11/29/2012WO2012160333A2 Recombinant yeast
11/29/2012WO2012160223A1 Pharmaceutical composition
11/29/2012WO2012160213A1 Controlled release peptide formulations
11/29/2012WO2012160203A1 Mucosal delivery of drugs
11/29/2012WO2012160199A1 Inactivated dengue virus vaccine
11/29/2012WO2012160180A2 Pharmaceutical composition for administration to nails
11/29/2012WO2012160179A2 Topical pharmaceutical composition based on semifluorinated alkanes
11/29/2012WO2012160125A1 Compositions for percutaneous administration of physiologically active agents
11/29/2012WO2012159960A1 Pharmaceutical composition comprising fexofenadine
11/29/2012WO2012159945A1 Ifn-beta compositions, preparation methods and uses thereof
11/29/2012WO2012159552A1 Solid pharmaceutical composition containing benzimidazole derivative
11/29/2012WO2012159550A1 Fgfr-fc fusion protein and use thereof
11/29/2012WO2012159511A1 Azilsartan solid dispersion, preparation method and pharmaceutical compositions thereof
11/29/2012WO2012159215A1 Compositions and methods for efficacious and safe delivery of sirna using specific chitosan-based nanocomplexes
11/29/2012WO2012159197A1 Drug delivery agents comprising cyclodextrin covalently linked to a gemini surfactant, and pharmaceutical compositions comprising the same
11/29/2012WO2012159173A1 Dose measuring means for a medicine
11/29/2012WO2012139094A3 Method of developing a vaccine using peptide-poly ic complexes
11/29/2012WO2012131463A3 Controlled release pharmaceutical dosage forms
11/29/2012WO2012129429A3 Transdermal compositions comprising an active agent layer and an active agent conversion layer
11/29/2012WO2012125552A3 Methods of electric field induced delivery of compounds, compositions used in delivery, and system of delivery
11/29/2012WO2012098562A3 Liquid oral compositions of lanthanum salts
11/29/2012US20120302816 Therapeutic compositions and methods for targeted delivery of active agents
11/29/2012US20120302794 Derivatives of venlafaxine and methods of preparing and using the same
11/29/2012US20120302761 Intermediates useful in the preparation of maleimide functionalized polymers
11/29/2012US20120302648 Implant material and a method for producing same
11/29/2012US20120302635 Water-Swellable Polymers
11/29/2012US20120302634 Skin protection compositions, in particular cream to protect against cold
11/29/2012US20120302557 Biologically active methylene blue derivatives
11/29/2012US20120302528 Bioabsorbable polymer compositions exhibiting enhanced crystallization and hydrolysis rates
11/29/2012US20120302514 Glycoconjugates and methods
11/29/2012US20120302445 Process for recycling polymer fines
11/29/2012US20120301546 Acid-resistant soft gel compositions
11/29/2012US20120301541 Compressed core for pharmaceutical composition
11/29/2012US20120301518 Biocompatible and biodegradable elastomeric polymers
11/29/2012US20120301516 Particle- containing complex porous materials
11/29/2012US20120301500 Anti-sepsis conjugate vaccine
11/29/2012US20120301441 Dextran-hyaluronic acid based hydrogels
11/29/2012US20120301436 Polyelectrolyte complex gels and soft tissue augmentation implants comprising the same
11/29/2012US20120301424 Cyclodextrin-based polymers for therapeutics delivery
11/29/2012US20120301401 Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions
11/29/2012US20120301397 Diagnosis of macrophage mediated disease
11/29/2012CA2837327A1 Immunoconjugates, compositions containing them, and methods of making and use
11/29/2012CA2837170A1 Modular transport platform for targeted delivery of therapeutic agents
11/29/2012CA2837145A1 Inactivated dengue virus vaccine
11/29/2012CA2837104A1 Amylin peptides and derivatives and uses thereof
11/29/2012CA2836891A1 Method for preparing microparticles with reduced initial burst and microparticles prepared thereby
11/29/2012CA2836873A1 Deimmunized serum-binding domains and their use for extending serum half-life
11/29/2012CA2836865A1 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
11/29/2012CA2836847A1 Controlled release peptide formulations
11/29/2012CA2836831A1 Pharmaceutical composition
11/29/2012CA2835912A1 Pharmaceutical composition comprising fexofenadine
11/29/2012CA2835716A1 Compositions for percutaneous administration of physiologically active agents
11/29/2012CA2835147A1 Compositions and methods for efficacious and safe delivery of sirna using specific chitosan-based nanocomplexes
11/29/2012CA2834862A1 Pharmaceutical composition for administration to nails
11/29/2012CA2834855A1 Topical pharmaceutical composition based on semifluorinated alkanes
11/29/2012CA2834806A1 Drug delivery agents comprising cyclodextrin covalently linked to a gemini surfactant, and pharmaceutical compositions comprising the same
11/29/2012CA2834584A1 Fgfr-fc fusion protein and use thereof
11/28/2012EP2527440A1 Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
11/28/2012EP2527360A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
11/28/2012EP2527008A2 Anticancerous polymeric agents
11/28/2012EP2527006A1 Quetiapine Formulation Having a Controlled-Release Coating
11/28/2012EP2526996A1 Intracutaneous injection
11/28/2012EP2526972A1 A conjugate of an antibody against CD4 and antifusogenic peptides
11/28/2012EP2526971A1 Mucosal delivery of drugs
11/28/2012EP2526963A1 Solution preparation containing stabilized antibody
11/28/2012EP2526962A1 Therapeutic application of Kazal-type serine protease inhibitors
11/28/2012EP2526940A2 Compositions containing enantiomeric equol, and methods for their making
11/28/2012EP2526930A1 Vitamin formulation
11/28/2012EP2526929A1 Ophthalmic compositions containing a synergistic combination of two polymers
11/28/2012EP2526923A1 Ophthalmic gel of gatifloxacin and preparation method thereof
11/28/2012EP2526421A2 Detection of early-stage pancreatic adenocarcinoma
11/28/2012EP2525835A2 Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery
11/28/2012EP2525834A1 Growth hormones with prolonged in-vivo efficacy
11/28/2012EP2525833A2 Stable growth hormone compounds
11/28/2012EP2525832A1 Cancer stem cell markers and uses thereof
11/28/2012EP2525831A1 Carrier-linked carbamate prodrug linkers
11/28/2012EP2525830A1 Dipeptide-based prodrug linkers for aliphatic amine-containing drugs
11/28/2012EP2525829A1 Dipeptide-based prodrug linkers for aromatic amine-containing drugs
11/28/2012EP2525828A2 Stabilized proteases for use in skin care
11/28/2012EP2525826A2 Pharmaceutical formulation for proteins
11/28/2012EP2525818A2 Immunogenic influenza composition
11/28/2012EP2525803A2 Antimicrobial agent comprising peroxide, alcohol and chelating agent
11/28/2012EP2525798A1 Anaesthetic formulation
11/28/2012EP2525791A2 Special composition for the use thereof as a drug
11/28/2012EP2525787A2 Liquid formulations for long-acting g-csf conjugate
11/28/2012EP2525782A2 Formulations of nano-carriers and methods of preparing the same
11/28/2012EP2525780A2 Synthetic nanostructures including nucleic acids and/or other entities
11/28/2012EP2525777A2 Material and method for treating internal cavities
11/28/2012EP2525776A2 Intracameral sustained release therapeutic agent implants
11/28/2012CN1916001B Method of producing addition products of compounds containing sih groups onto reactants having one double bond on aqueous media
11/28/2012CN1889965B Use of biocompatible polymers for the preparation of a composition or a medical device
1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 1712